摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-acetyl-1-propylimidazole | 600638-89-9

中文名称
——
中文别名
——
英文名称
5-acetyl-1-propylimidazole
英文别名
1-(1-Propyl-1H-imidazol-5-yl)ethan-1-one;1-(3-propylimidazol-4-yl)ethanone
5-acetyl-1-propylimidazole化学式
CAS
600638-89-9
化学式
C8H12N2O
mdl
MFCD08668281
分子量
152.196
InChiKey
PZFQYXXXEDFAPL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    34.9
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • [EN] DERIVATIVES OF 4- (IMIDAZOL-5-YL)-2-(4-SULFOANILINO) PYRIMIDINE WITH CDK INHIBITORY ACTIVITY<br/>[FR] DERIVES DE 4- (IMIDAZOL-5-YL)-2-(4-SULFOANILINO) PYRIMIDINE A ACTIVITE INHIBITRICE CDK
    申请人:ASTRAZENECA AB
    公开号:WO2003076436A1
    公开(公告)日:2003-09-18
    Compounds of the formula (I): wherein R1, R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
    公式(I)的化合物:其中R1、R2、R3、R4、R5和p的定义如下,并且描述了药学上可接受的盐和体内可解酯。还描述了它们的制备过程以及它们作为药物的用途,特别是作为用于在温血动物(如人)中产生细胞周期抑制(抗细胞增殖)效果的药物。
  • Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
    申请人:Newcombe John Nicholas
    公开号:US20050131000A1
    公开(公告)日:2005-06-16
    Compounds of the formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
    本文描述了化学式(I)的化合物,其中R1、R2、R3、R4、R5和p的定义如本文中所述,并描述了其药物学上可接受的盐和体内可解的酯。同时还描述了它们的制备过程以及它们作为药物的用途,特别是作为产生对温血动物(如人)的细胞周期抑制(抗细胞增殖)效应的药物。
  • DERIVATIVES OF 4-(IMIDAZOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE WITH CDK INHIBITORY ACTIVITY
    申请人:AstraZeneca AB
    公开号:EP1487823A1
    公开(公告)日:2004-12-22
  • US7465728B2
    申请人:——
    公开号:US7465728B2
    公开(公告)日:2008-12-16
查看更多